title: A double closed loop to enhance the quality of life of Parkinson's Disease patients: REMPARK system.
abstract: This paper presents REMPARK system, a novel approach to deal with Parkinson's Disease (PD). REMPARK system comprises two closed loops of actuation onto PD. The first loop consists in a wearable system that, based on a belt-worn movement sensor, detects movement alterations that activate an auditory cueing system controlled by a smartphone in order to improve patient's gait. The belt-worn sensor analyzes patient's movement through real-time learning algorithms that were developed on the basis of a database previously collected from 93 PD patients. The second loop consists in disease management based on the data collected during long periods and that enables neurologists to tailor medication of their PD patients and follow the disease evolution. REMPARK system is going to be tested in 40 PD patients in Spain, Ireland, Italy and Israel. This paper describes the approach followed to obtain this system, its components, functionalities and trials in which the system will be validated.
authors.affiliation: CETpD, Universitat Politècnica de Catalunya (UPC), Vilanova i la Geltrú, Spain.
authors.forename: Albert
authors.initials: A
authors.lastname: Samà
authors.affiliation: CETpD, Universitat Politècnica de Catalunya (UPC), Vilanova i la Geltrú, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Pérez-López
authors.affiliation: CETpD, Universitat Politècnica de Catalunya (UPC), Vilanova i la Geltrú, Spain.
authors.forename: Daniel
authors.initials: D
authors.lastname: Rodríguez-Martín
authors.affiliation: CETpD, Universitat Politècnica de Catalunya (UPC), Vilanova i la Geltrú, Spain.
authors.forename: J Manuel
authors.initials: JM
authors.lastname: Moreno-Aróstegui
authors.affiliation: Telefónica I+D, Barcelona/Granada, Spain.
authors.forename: Jordi
authors.initials: J
authors.lastname: Rovira
authors.affiliation: Neusta mobile solutions GmbH, Bremen, Germany.
authors.forename: Claas
authors.initials: C
authors.lastname: Ahlrichs
authors.affiliation: Fraunhofer Portugal AICOS, Porto, Portugal.
authors.forename: Rui
authors.initials: R
authors.lastname: Castro
authors.affiliation: Fraunhofer Portugal AICOS, Porto, Portugal.
authors.forename: João
authors.initials: J
authors.lastname: Cevada
authors.affiliation: Fraunhofer Portugal AICOS, Porto, Portugal.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Graça
authors.affiliation: Fraunhofer Portugal AICOS, Porto, Portugal.
authors.forename: Vânia
authors.initials: V
authors.lastname: Guimarães
authors.affiliation: Fraunhofer Portugal AICOS, Porto, Portugal.
authors.forename: Bernardo
authors.initials: B
authors.lastname: Pina
authors.affiliation: Electrical & Electronic Engineering Department, NUI Galway (NUIG), Ireland.
authors.forename: Timothy
authors.initials: T
authors.lastname: Counihan
authors.affiliation: Maccabi Healthcare Services, Tel-Aviv, Israel.
authors.forename: Hadas
authors.initials: H
authors.lastname: Lewy
authors.affiliation: IRCCS Fondazione Santa Lucia, Roma, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Annicchiarico
authors.affiliation: Parkinson's Disease Unit, Teknon Medical Center, Barcelona, Spain.
authors.forename: Angels
authors.initials: A
authors.lastname: Bayés
authors.affiliation: Electrical & Electronic Engineering Department, NUI Galway (NUIG), Ireland.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Rodríguez-Molinero
authors.affiliation: CETpD, Universitat Politècnica de Catalunya (UPC), Vilanova i la Geltrú, Spain.
authors.forename: Joan
authors.initials: J
authors.lastname: Cabestany
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage; D001676:Biofeedback, Psychology / Q000295:instrumentation / Q000379:methods*; D016903:Drug Monitoring / Q000295:instrumentation / Q000379:methods; D004867:Equipment Design; D006801:Humans; D018670:Monitoring, Ambulatory / Q000295:instrumentation / Q000379:methods; D010300:Parkinson Disease / Q000175:diagnosis* / Q000628:therapy*; D011788:Quality of Life; D018511:Systems Integration; D017216:Telemedicine / Q000295:instrumentation / Q000379:methods*; D013813:Therapy, Computer-Assisted / Q000295:instrumentation / Q000379:methods*
chemical_list: D000978:Antiparkinson Agents